88755-39-9 Usage
Uses
Used in Pharmaceutical Production:
2,4-bis(1,3-benzodioxol-5-yl)-4-oxobutanoic acid is used as a key intermediate in the synthesis of various pharmaceuticals due to its potential anti-inflammatory and anti-cancer properties. Its presence in these compounds can enhance their therapeutic effects and contribute to the development of new treatments for various diseases.
Used in Organic Synthesis as a Reagent:
In the field of organic synthesis, BDBOA is utilized as a reagent for the preparation of a wide range of biologically active compounds. Its unique structure allows for versatile chemical reactions, making it a valuable component in the creation of new molecules with potential applications in medicine and other industries.
Used in Research and Development:
2,4-bis(1,3-benzodioxol-5-yl)-4-oxobutanoic acid is also used in research and development settings to explore its potential applications in various fields. Scientists are interested in its anti-inflammatory and anti-cancer properties, and ongoing studies aim to uncover new ways to harness these effects for the benefit of human health.
Used in Drug Discovery:
BDBOA is employed as a lead compound in drug discovery processes, where its structure and reactivity are leveraged to identify potential therapeutic agents. Its role in this process is crucial for the development of innovative medications that can address unmet medical needs.
Check Digit Verification of cas no
The CAS Registry Mumber 88755-39-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,7,5 and 5 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 88755-39:
(7*8)+(6*8)+(5*7)+(4*5)+(3*5)+(2*3)+(1*9)=189
189 % 10 = 9
So 88755-39-9 is a valid CAS Registry Number.
88755-39-9Relevant academic research and scientific papers
Studies on the chemical constituents of rutaceous plants. L. Development of a versatile method for the synthesis of antitumor-active benzo[c]phenanthridine alkaloids. (2). Preparation of 2-aryl-1-tetralone derivatives
Ishii,Kawanabe,Harada,et al.
, p. 3039 - 3055 (2007/10/02)
The synthetic pathway from 2,4-bisaryl-4-oxobutyramide (3) to 2-aryl-1-tetralone (4), which is the key intermediate in the Robinson synthesis of antitumor-active benzo[c]phenanthridine alkaloids was improved. Treatment of the model keto-amide (3a) under the reported basic conditions gave γ-keto-α,β-unsaturated acid (9) and degradation products. Reduction of the 2,4-bisaryl-4-oxobutyramide (3) with sodium borohydride gave 2,4-bisaryl-4-hydroxybutyramide (16) which could easily be hydrogenolyzed to give 2,4-bisarylbutyramide (15). However, this transformation also tended to give a γ-lactam derivative (17), unfortunately. We succeeded in the direct hydrogenolysis of the 2,4-bisaryl-4-oxobutyramide (3) to the 2,4-bisarylbutyramide (15), which could be hydrolyzed to the corresponding acid (5) without difficulty. The direct hydrolysis of the 2,4-bisaryl-4-oxobutyronitrile (2) to the 2,4-bisaryl-4-oxobutyric acid (6) as reported by Cheng et al. was also examined. Ten 2-aryl-1-tetralones (4) required as starting materials for syntheses of various benzo[c]phenanthridine alkaloids were prepared.
